Administration of chemotherapy via the median cubital vein without implantable central venous access ports: port-free chemotherapy for metastatic colorectal cancer patients
- 442 Downloads
Repeated venous punctures are usually required during chemotherapy administration for cancer patients. Central venous catheters and implantable port systems have substantially facilitated vascular access, and safe, easy-to-handle port systems have become an integral part of daily clinical routines in oncology. However, several serious complications are associated with central venous ports (CV-ports), and recent developments of combined oral capecitabine and oxaliplatin (XELOX) therapies allow CV-port-free administration. In this study, the safety and efficacy of CV-port-free chemotherapy administration via the median cubital vein was assessed in metastatic colorectal cancer patients.
This study included 144 patients who received XELOX + bevacizumab (BV) or XELOX therapy for metastatic colorectal cancer without CV-port implantation.
Eighty-five patients experienced transient vascular pain. The drip infusion route was switched to the opposite side following vascular pain in only 1 patient. No patients required CV-port implantation or delayed treatment due to adverse events associated with drug administration via the peripheral vein. Grade 3 or higher hemotoxicity and grade 3 or higher non-hematological toxicity was noted in 12.5 and 17.4 % of patients, respectively.
Port-free-chemotherapy administration via the median cubital vein is appropriate for patients with colorectal cancer, thereby avoiding complications associated with CV-ports.
KeywordsChemotherapy Colorectal cancer Central venous port Median cubital vein
Conflict of interest
The authors declare that they have no conflict of interest.
- 12.Jordan K, Behlendorf T, Surov A et al (2008) Venous access ports: frequency and management of complications in oncology patients. Onkologie 31(404–410):14Google Scholar
- 13.Fonkalsrud EW, Pederson BM, Murphy J et al (1968) Reduction of infusion thrombophlebitis with buffered glucose solutions. Surgery 63:280–284Google Scholar
- 24.Vardy J, Engelhardt K, Cox K et al (2004) Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature. Br J Cancer 91:1045–1049PubMedCentralPubMedGoogle Scholar
- 32.Yoshida Y (2012) Port free chemotherapy for recurrent or metastatic colorectal cancer. Is port really necessary? J Cancer Sci Ther 4:iv–iv. doi: 10.4172/1948-5956.1000e105